Research Article
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
Table 1
Plasma Gas6, sAxl, and sMerTK concentrations at different time points (t0, t7, and t14). Values are expressed as median (IQR).
| | Laboratory findings (ng/ml) | Median (IQR) |
| | Gas6 | | | t0 | 46.8 (38.2-59.6) | | t7 | 36.6 (27.7-45.9) | | t14 | 36.1 (28.1-41.7) | | sAxl | | | t0 | 16.7 (10.7-27.4) | | t7 | 26.2 (14.9-39.6) | | t14 | 22.5 (15.7-29.8) | | sMerTK | | | t0 | 33.7 (25.3-38.4) | | t7 | 28.0 (21.4-34.8) | | t14 | 24.3 (21.2-30.3) |
|
|